Effect of hormone replacement therapy on insulin secretion and insulin sensitivity in postmenopausal diabetic women

Gynecological Endocrinology

Volumn 16, Issue 1, 2002, Pages 67-74

  Borissova, A M ^a   Tankova, T ^a   Kamenova, P ^a   Dakovska, L ^a   Kovacheva, R ^a   Kirilov, G ^a   Genov, N ^a   Milcheva, B ^a   Koev, D ^a  

^a UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

Hormone Replacement Therapy; Insulin Resistance; Oxidative Stress; Cell Insulin Secretion

Indexed keywords

ACTRAPIC; ANTIOXIDANT; CYPROTERONE ACETATE; CYPROTERONE ACETATE PLUS ESTRADIOL VALERATE; DYDROGESTERONE; DYDROGESTERONE PLUS ESTRADIOL; ESTRADIOL; GLIPIZIDE; GLUCOSE; INSULIN; SYSTEM TTS 50;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE CLAMP TECHNIQUE; HORMONE SUBSTITUTION; HUMAN; HYPERINSULINEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; INSULINEMIA; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID BLOOD LEVEL; MENOPAUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0036130474     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/gye.16.1.67.74     Document Type: Article

References (34)

1. Undiagnosed NIDDM: Clinical and public health issues
2. Age as independent determinant of glucose tolerance
3. HRT in menopausal women with diabetes: Benefits and risks
4. Carbohydrate metabolism in postmenopausal women using oral estradiol and dydrogesterone
5. Hormone replacement therapy and carbohydrate metabolism
6. Principles and practice of hormone replacement therapy in women with manifest diabetes
7. Drug therapy for postmenopausal osteoporosis: Current controversies
8. Estrogen and cardiovascular function after menopause
9. Osteoporosis: Review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis
10. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type 1 diabetes
11. Standardization of IVGTT to predict IDDM
12. Glucose clamp technique: A method for quantifying insulin secretion and resistance
13. Serum oxidation activity and rheumatoid arthritis
14. Plasma SOD - Activity in IDDM-children
15. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients
16. Predicting age at menopause
17. The menopause and society
18. An update on implications of phasic insulin secretion
19. Pathogenesis of NIDDM: A precarious balance between insulin action and insulin secretion
20. Banting lecture 1990. Beta-cells in type II diabetes mellitus
21. Free radical activity and haemostatic factors in NIDDM patients with and without microalbuminuria
22. Free radicals in diabetic endothelial cell dysfunction
23. Basal nitric oxide turnover and oxidative stress levels in insulin-dependent diabetes mellitus
24. Antioxidants: A biological defense mechanism for the prevention of atherosclerosis
25. The effects of oestrogens on vessel wall and cardiac function, haemostasis and homocysteine metabolism
26. Estrogen replacement therapy continuously combined with four different dosages of dydrogesterone; effect on calcium and lipid metabolism